Univercells focuses on increasing the availability of affordable vaccines and biotherapeutics to address global health challenges. The company is developing turnkey solutions for a series of vaccines and biotherapeutics to be delivered at an affordable price.


For this purpose, Univercells has developed an innovative manufacturing platform based on a disruptive setup, with improvements introduced at each step of the manufacturing process, resulting in a drastic reduction of the size of the manufacturing facility, while optimizing its performance.


This highly innovative and patent pending technology platform allows Univercells to rapidly deploy autonomous multi-product micro-facilities, more cost-effective to build (drastic capital investment reduction) and to operate (significantly lower operational costs), while offering flexible capabilities.